NRx Pharmaceuticals (NRXPW) has had the highest return since October 1, 2025 by a small-cap US stock, returning 90.8%.
| ASSET | % RETURN |
|---|---|
NRx Pharmaceuticals (NRXPW) | 90.79% |
Larimar Therapeutics (LRMR) | 50.77% |
USA Rare Earth (USAR) | 48.13% |
Richtech Robotics Inc Class B Common Stock (RR) | 47.14% |
Taysha Gene Therapies (TSHA) | 46.46% |
Clene (CLNNW) | 45.63% |
Canaan (CAN) | 42.59% |
enGene Holdings Inc Common Stock (ENGN) | 39.28% |
AC Immune (ACIU) | 37.59% |
Destiny Tech100 (DXYZ) | 37.27% |
American Resources Corp Class A (AREC) | 35.53% |
Critical Metals Corp Ordinary Shares (CRML) | 31.9% |
Arqit Quantum (ARQQ) | 31.42% |
FuelCell Energy (FCEL) | 30.31% |
Ballard Power Systems (BLDP) | 28.83% |
GDEV (GDEV) | 28.48% |
Blacksky Technology (BKSY) | 28.31% |
Lightwave Logic (LWLG) | 27.03% |
Solid Power (SLDP) | 26.32% |
Spire Global (SPIR) | 26.31% |
Clearpoint Neuro (CLPT) | 26.23% |
Eos Energy Enterprises (EOSEW) | 25.99% |
Mobilicom Limited Warrants (MOBBW) | 25.9% |
Red Cat (RCAT) | 25.51% |
Esperion Therapeutics (ESPR) | 25.48% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
